Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Arrowhead Pharmaceuticals...

    NASDAQ: ARWR · Real-Time Price · USD
    15.50
    -0.46 (-2.88%)
    At close: Jun 25, 2025, 10:37 AM

    Arrowhead Pharmaceuticals Statistics

    Share Statistics

    Arrowhead Pharmaceuticals has 138.1M shares outstanding. The number of shares has increased by 10.56% in one year.

    Shares Outstanding

    n/a
    		 138.1M

    Shares Change (YoY)

    n/a
    		 10.56%

    Shares Change (QoQ)

    n/a
    		 10.35%

    Owned by Institutions (%)

    n/a
    		 79.96%

    Shares Floating

    n/a
    		 115.2M

    Failed to Deliver (FTD) Shares

    n/a
    		 11,100

    FTD / Avg. Volume

    n/a
    		 0.6%

    Short Selling Information

    The latest short interest is 13.31M, so 9.64% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.31M

    Short % of Shares Out

    n/a
    		 9.64%

    Short % of Float

    n/a
    		 12.44%

    Short Ratio (days to cover)

    n/a
    		 7.46

    Valuation Ratios

    The PE ratio is -3.87 and the forward PE ratio is -4.56. Arrowhead Pharmaceuticals's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -3.87

    Forward PE

    n/a
    		 -4.56

    PS Ratio

    n/a
    		 653.4

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 12.51

    P/FCF Ratio

    n/a
    		 -3.84

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Arrowhead Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.74, with a Debt / Equity ratio of 2.75.

    Current Ratio

    n/a
    		 6.74

    Quick Ratio

    n/a
    		 6.74

    Debt / Equity

    n/a
    		 2.75

    Debt / EBITDA

    n/a
    		 -0.91

    Debt / FCF

    n/a
    		 -0.84

    Interest Coverage

    n/a
    		 -18.58

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $583,087.03

    Profits Per Employee

    n/a
    		 $-984,389.16

    Employee Count

    n/a
    		 609

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.77M

    Effective Tax Rate

    n/a
    		 0.45%

    Stock Price Statistics

    The stock price has increased by -40.6% in the last 52 weeks. The beta is 0.95, so Arrowhead Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.95

    52-Week Price Change

    n/a
    		 -40.6%

    50-Day Moving Average

    n/a
    		 14.7

    200-Day Moving Average

    n/a
    		 18.04

    Relative Strength Index (RSI)

    n/a
    		 53.31

    Average Volume (20 Days)

    n/a
    		 1,852,062

    Income Statement

    In the last 12 months, Arrowhead Pharmaceuticals had revenue of 355.1M and earned -599.49M in profits. Earnings per share was -5.

    Revenue

    n/a
    		 355.1M

    Gross Profit

    n/a
    		 355.1M

    Operating Income

    n/a
    		 -601.08M

    Net Income

    n/a
    		 -599.49M

    EBITDA

    n/a
    		 -561.51M

    EBIT

    n/a
    		 -580.11M

    Earnings Per Share (EPS)

    n/a
    		 -5
    Full Income Statement

    Balance Sheet

    The company has 102.69M in cash and 510.55M in debt, giving a net cash position of -407.87M.

    Cash & Cash Equivalents

    n/a
    		 102.69M

    Total Debt

    n/a
    		 510.55M

    Net Cash

    n/a
    		 -407.87M

    Retained Earnings

    n/a
    		 -1.63B

    Total Assets

    n/a
    		 1.57B

    Working Capital

    n/a
    		 142.44M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -462.85M and capital expenditures -141.47M, giving a free cash flow of -604.32M.

    Operating Cash Flow

    n/a
    		 -462.85M

    Capital Expenditures

    n/a
    		 -141.47M

    Free Cash Flow

    n/a
    		 -604.32M

    FCF Per Share

    n/a
    		 -5.05
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -16927.06% and -16882.37%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -16927.06%

    Pretax Margin

    n/a
    		 -17247.54%

    Profit Margin

    n/a
    		 -16882.37%

    EBITDA Margin

    n/a
    		 -15812.81%

    EBIT Margin

    n/a
    		 -169.27%

    FCF Margin

    n/a
    		 -170.18%

    Dividends & Yields

    ARWR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ARWR is $42, which is 163.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $42

    Price Target Difference

    n/a
    		 163.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 17, 2011. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Nov 17, 2011

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 1.72

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist